Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly R Reveles

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Hospital Practice (1995)|October 4, 2019
Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care SystemMarilyn L Mootz, Rachel S Britt, Allison A Mootz, et al.
Journal of Substance Abuse Treatment|November 3, 2020
National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016Kirk E Evoy, Laura Roccograndi, Samantha Le, et al.
Pharmacotherapy|February 3, 2018
Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of VeteransKelly R Reveles, Eric M Mortensen, Jim M Koeller, et al.
Microorganisms|May 25, 2024
Developing the Common Marmoset as a Translational Geroscience Model to Study the Microbiome and Healthy AgingKelly R Reveles, Alexana J Hickmott, Kelsey A Strey, et al.
Addiction (Abingdon, England)|November 3, 2020
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USALucas G Hill, Lindsey J Loera, Kirk E Evoy, et al.
Open Forum Infectious Diseases|July 15, 2024
Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non-<i>Clostridioides difficile</i> Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label StudyKelly R Reveles, Anne J Gonzales-Luna, Yoav Golan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases Society of America Strategic PlanCynthia L Sears, Thomas M File, Barbara D Alexander, et al.
Geroscience|September 29, 2023
Changes in oral health during aging in a novel non-human primate modelParveez Ahamed Abdul-Azees, Hanzhou Wang, Yong-Hee P Chun, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Validation of Body Condition Scoring as a Screening Test for Low Body Condition and Obesity in Common Marmosets ( <i>Callithrix jacchus</i> )Juan Pablo Arroyo, Addaline Alvarez, Lori Alvarez, et al.
American Journal of Primatology|August 20, 2025
Validation of Body Condition Scoring as a Screening Test for Low Body Condition and Obesity in Common Marmosets (Callithrix jacchus)Juan Pablo Arroyo, Addaline Alvarez, Lori Alvarez, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Hospital Practice (1995)|October 4, 2019
Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care SystemMarilyn L Mootz, Rachel S Britt, Allison A Mootz, et al.
Journal of Substance Abuse Treatment|November 3, 2020
National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016Kirk E Evoy, Laura Roccograndi, Samantha Le, et al.
Pharmacotherapy|February 3, 2018
Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of VeteransKelly R Reveles, Eric M Mortensen, Jim M Koeller, et al.
Microorganisms|May 25, 2024
Developing the Common Marmoset as a Translational Geroscience Model to Study the Microbiome and Healthy AgingKelly R Reveles, Alexana J Hickmott, Kelsey A Strey, et al.
Addiction (Abingdon, England)|November 3, 2020
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USALucas G Hill, Lindsey J Loera, Kirk E Evoy, et al.
Open Forum Infectious Diseases|July 15, 2024
Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non-<i>Clostridioides difficile</i> Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label StudyKelly R Reveles, Anne J Gonzales-Luna, Yoav Golan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases Society of America Strategic PlanCynthia L Sears, Thomas M File, Barbara D Alexander, et al.
Geroscience|September 29, 2023
Changes in oral health during aging in a novel non-human primate modelParveez Ahamed Abdul-Azees, Hanzhou Wang, Yong-Hee P Chun, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Validation of Body Condition Scoring as a Screening Test for Low Body Condition and Obesity in Common Marmosets ( <i>Callithrix jacchus</i> )Juan Pablo Arroyo, Addaline Alvarez, Lori Alvarez, et al.
American Journal of Primatology|August 20, 2025
Validation of Body Condition Scoring as a Screening Test for Low Body Condition and Obesity in Common Marmosets (Callithrix jacchus)Juan Pablo Arroyo, Addaline Alvarez, Lori Alvarez, et al.
Pageof 9